Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Unforeseen outcomes: Unveiling cyst formation post stereotactic radiosurgery in brain arteriovenous malformations cases.
J Clin Neurosci
October 2024
Department of Neurosurgery, All India Institute of Medical Sciences, New-Delhi, India.
Introduction: Cyst formation after stereotactic radiosurgery (SRS) for brain arteriovenous malformations (AVMs) is a rare, delayed but important complication. Prompt recognition and appropriate treatment is essential for good outcome.
Methods: We analysed our institute's Gamma knife treatment records from 2008 to 2023 and analysed AVM treated patients by gamma knife radiosurgery (GKRS).
Biological effective dose as a predictor of local tumor control in stereotactic radiosurgery treated parasellar meningioma patients.
J Neurooncol
November 2024
Department of Neurological Surgery, University of Virginia, Box 800212, Charlottesville, VA, 22908, USA.
Introduction: The radio-surgical literature increasingly uses biological effective dose (BED) as a replacement for absorbed dose to analyze outcome of stereotactic radiosurgery (SRS). There are as yet no studies which specifically investigate the association of BED to local tumor control in para-sellar meningioma.
Methods: we did a retrospective analysis of patients underwent stereotactic radiosurgery (SRS) for para-sellar meningioma during the period of 1995-2022.
[Issues and implementation of postoperative radiotherapy after flap reconstructive surgery in head and neck cancers].
Bull Cancer
May 2024
Department of radiotherapy, Centre François-Baclesse, Corpuscular Physics Laboratory, IN2P3, Ensicaen, CNRS UMR 6534, Université de Normandie, GORTEC, Caen, France.
The management of head and neck cancers is multidisciplinary, often relying on the use of combined treatments to maximize the chances of cure. Combined treatments are however also responsible for cumulative side effects. The aim of reconstructive surgery with a flap is to restore a function lost with the loss of substance from the tumor resection.
View Article and Find Full Text PDFReal-world experience with 11C-methionine positron emission tomography in the management of acromegaly.
Eur J Endocrinol
March 2024
Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Background: L-[methyl-11C]-methionine-positron emission tomography (Met-PET) is a potentially important imaging adjunct in the diagnostic workup of pituitary adenomas, including somatotroph tumors. Met-PET can identify residual or occult disease and make definitive therapies accessible to a subgroup of patients who would otherwise require lifelong medical therapy. However, existing data on its use are still limited to small case series.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!